Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA.
Physiol Rep. 2024 Jun;12(12):e16114. doi: 10.14814/phy2.16114.
Although the liver is the largest metabolic organ in the body, it is not alone in functionality and is assisted by "an organ inside an organ," the gut microbiota. This review attempts to shed light on the partnership between the liver and the gut microbiota in the metabolism of macronutrients (i.e., proteins, carbohydrates, and lipids). All nutrients absorbed by the small intestines are delivered to the liver for further metabolism. Undigested food that enters the colon is metabolized further by the gut microbiota that produces secondary metabolites, which are absorbed into portal circulation and reach the liver. These microbiota-derived metabolites and co-metabolites include ammonia, hydrogen sulfide, short-chain fatty acids, secondary bile acids, and trimethylamine N-oxide. Further, the liver produces several compounds, such as bile acids that can alter the gut microbial composition, which can in turn influence liver health. This review focuses on the metabolism of these microbiota metabolites and their influence on host physiology. Furthermore, the review briefly delineates the effect of the portosystemic shunt on the gut microbiota-liver axis, and current understanding of the treatments to target the gut microbiota-liver axis.
虽然肝脏是人体最大的代谢器官,但它并非孤立运作,而是由“一个器官内的器官”——肠道微生物群辅助代谢。本综述旨在阐明肝脏与肠道微生物群在宏量营养素(即蛋白质、碳水化合物和脂质)代谢中的关系。小肠吸收的所有营养素都被输送到肝脏进行进一步代谢。进入结肠的未消化食物进一步被肠道微生物群代谢,产生次级代谢物,这些代谢物被吸收到门静脉循环中并到达肝脏。这些源自微生物群的代谢物和共代谢物包括氨、硫化氢、短链脂肪酸、次级胆汁酸和三甲胺 N-氧化物。此外,肝脏还会产生一些化合物,如胆汁酸,这些物质可以改变肠道微生物群落组成,从而影响肝脏健康。本综述重点介绍了这些微生物群代谢物的代谢及其对宿主生理的影响。此外,还简要阐述了门体分流对肠道微生物群-肝脏轴的影响,以及目前针对肠道微生物群-肝脏轴的治疗方法的理解。